OTC · RBGLY
Consumer Defensive · Household & Personal Products
$13.70
Up+$0.11 (+0.81%)
Updated Oct 10, 2026, 1:32 AM
SID Score
4.1/10
Composite research score
Smart Money
46/100
Neutral
Price performance · RBGLY
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
RBGLY closed at $13.71 after 21 trading sessions, up 0.37% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $13.63 | $13.72 | $13.5893 | $13.71 | 646.44K |
| Oct 8, 2026 | $13.578 | $13.62 | $13.4382 | $13.59 | 870.2K |
| Oct 7, 2026 | $13.64 | $13.65 | $13.49 | $13.61 | 427.98K |
| Oct 6, 2026 | $13.18 | $13.35 | $13.15 | $13.30 | 659.71K |
| Oct 5, 2026 | $13.132 | $13.155 | $12.96 | $13.09 | 391.23K |
| Oct 2, 2026 | $13.1799 | $13.221 | $13.06 | $13.15 | 300.42K |
| Oct 1, 2026 | $13.14 | $13.16 | $13.00 | $13.05 | 505.11K |
| Sep 30, 2026 | $13.64 | $13.66 | $13.2115 | $13.32 | 399.94K |
| Sep 29, 2026 | $13.0099 | $13.09 | $12.95 | $13.08 | 327.43K |
| Sep 28, 2026 | $13.10 | $13.20 | $13.0625 | $13.14 | 423.62K |
| Sep 25, 2026 | $13.17 | $13.20 | $13.041 | $13.18 | 488.68K |
| Sep 24, 2026 | $13.2501 | $13.30 | $13.08 | $13.13 | 1.03M |
| Sep 23, 2026 | $13.45 | $13.48 | $13.24 | $13.26 | 295.61K |
| Sep 22, 2026 | $13.62 | $13.63 | $13.415 | $13.50 | 356.07K |
| Sep 21, 2026 | $13.33 | $13.46 | $13.269 | $13.44 | 427.06K |
| Sep 18, 2026 | $13.29 | $13.345 | $13.24 | $13.29 | 618.45K |
| Sep 17, 2026 | $13.62 | $13.63 | $13.4775 | $13.52 | 660.42K |
| Sep 16, 2026 | $13.78 | $13.80 | $13.64 | $13.68 | 288.35K |
| Sep 15, 2026 | $13.79 | $13.875 | $13.71 | $13.765 | 428.57K |
| Sep 14, 2026 | $13.91 | $14.01 | $13.82 | $13.97 | 612.54K |
| Sep 11, 2026 | $13.8145 | $13.84 | $13.60 | $13.66 | 566.55K |
The latest Smart Investors Daily articles mentioning RBGLY.
Company
Market Activity
Research & News
RBGLY research
Company profile and research snapshot.
RECKITT BENCKISR GP S/ADR
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Jun 16, 2026 | Jefferies | Hold | — |
| May 15, 2026 | RBC Capital Markets | Neutral | — |
| May 12, 2026 | Jefferies | Hold | — |
| Apr 28, 2026 | Deutsche | Hold | — |
| Apr 24, 2026 | Berenberg Bank | Buy | — |
No generated briefing is available yet.
Yahoo · Oct 1, 2026
Reckitt Benckiser Group PLC (LSE:RKT, OTCQX:RBGLY), the consumer health and hygiene company, faces differing forecasts from UBS and Jefferies ahead of its third-quarter trading update, with both brokers retaining ‘buy’ ratings but taking different views on near-term growth. UBS expects group...
Yahoo · Sep 16, 2026
Reckitt today announced up to a $600 million, multi-year transformation of its U.S. operations across two sites to accelerate the long-term growth of its U.S. business. Investments will include relocation and integration of its commercial and R&D capabilities into a campus in New Jersey and significantly expanded plans for its largest over-the-counter (OTC) manufacturing facility in North Carolina.
Benzinga · Sep 16, 2026
https://www.wsj.com/logistics-report/mucinex-maker-bets-400-million-more-on-u-s-supply-chain-5c795042
Yahoo · Sep 15, 2026
Reckitt does not need to win a vendor slot or navigate Costco’s notoriously demanding supplier requirements. It is already approved, integrated, and selling.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.
The latest Smart Investors Daily articles mentioning RBGLY.
